Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App aims to unlock words after stroke

NCT ID NCT07570264

Symptom relief Sponsor: Nunaps Inc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a digital app called LEXURE can improve language skills in people who have trouble speaking after a stroke (aphasia). About 116 adults who had a stroke at least 3 months ago will either use the app or do workbook exercises. The goal is to see if the app helps them speak better after 10 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 116 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosed with hemorrhagic or ischemic stroke 2. At least 3 months have elapsed since stroke onset 3. History of aphasia resulting from stroke 4. Aphasia Quotient (AQ) score between 26 and 90 (inclusive) on the Korean version of the Western Aphasia Battery (K-WAB) or the Paradise Korean version of the Western Aphasia Battery-Revised (PK-WAB-R) 5. Adults aged 19 years or older 6. Native Korean speakers 7. Able to use the investigational device or perform workbook-based training without difficulty 8. Willing to participate voluntarily and provide written informed consent Exclusion Criteria: 1. Diagnosed with language impairment due to causes other than stroke (e.g., traumatic brain injury, brain tumor, or neurodegenerative disease) 2. History of language impairment due to developmental disorders 3. Currently receiving speech-language therapy or participating in another clinical trial related to language function 4. Currently receiving medication for severe psychiatric disorders (e.g., bipolar disorder, major depressive disorder, schizophrenia, alcohol dependence, or substance abuse) 5. Illiterate individuals 6. Individuals deemed unsuitable for participation in this study by the investigator 7. Severe cognitive impairment that would interfere with understanding or performing the study interventions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aphasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

aphasia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aphasia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asan Medical Center

    RECRUITING

    Seoul, 05505, South Korea

  • Chonnam National University Hospital

    RECRUITING

    Gwangju, 61469, South Korea

  • Hallym University Chuncheon Sacred Heart Hospital

    RECRUITING

    Chuncheon, 24253, South Korea

  • Inje University Busan Paik Hospita

    RECRUITING

    Busan, 47392, South Korea

  • Inje University Ilsan Paik Hospital

    RECRUITING

    Ilsan, 10380, South Korea

  • Jeonbuk National University Hospital

    NOT_YET_RECRUITING

    Jeonju, 54907, South Korea

  • Keimyung University Dongsan Hospital

    RECRUITING

    Daegu, 42601, South Korea

  • Konkuk University Medical Center

    RECRUITING

    Seoul, South Korea

  • Korea University Ansan Hospital

    NOT_YET_RECRUITING

    Ansan, Gyeonggi-do, 15355, South Korea

  • Kyungpook National University Hospital

    NOT_YET_RECRUITING

    Daegu, 41944, South Korea

  • Ulsan University Hospital

    RECRUITING

    Ulsan, 44033, South Korea

  • Yeungnam University Medical Center

    NOT_YET_RECRUITING

    Daegu, 42415, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.